APO Research
Talk to an analyst

APO RESEARCH · REPORT

Islet Amyloid Polypeptide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Islet Amyloid Polypeptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025184 pages

Choose your research edition.

Industry ResearchIslet Amyloid Polypeptide Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Islet Amyloid Polypeptide Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Islet Amyloid Polypeptide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Islet Amyloid Polypeptide Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Islet Amyloid Polypeptide Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Islet Amyloid Polypeptide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Islet Amyloid Polypeptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Islet Amyloid Polypeptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Islet Amyloid Polypeptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Islet Amyloid Polypeptide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Islet Amyloid Polypeptide include Adocia SAS, Neurimmune Holding AG, Nordic Bioscience A/S, Prothena Corp Plc, reMYND NV, Zealand Pharma AS, AstraZeneca Plc and Eli Lilly and Co, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Islet Amyloid Polypeptide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Islet Amyloid Polypeptide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Islet Amyloid Polypeptide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Islet Amyloid Polypeptide market size, projected growth trends, production technologies, key applications, and end-use industries.

Islet Amyloid Polypeptide Segment by Company

Adocia SAS

Neurimmune Holding AG

Nordic Bioscience A/S

Prothena Corp Plc

reMYND NV

Zealand Pharma AS

AstraZeneca Plc

Eli Lilly and Co

Islet Amyloid Polypeptide Segment by Type

KBP-088

KBP-056

DACRA-089

DACRA-042

AC-253

Others

Islet Amyloid Polypeptide Segment by Application

Gastrointestinal

Musculoskeletal Disorders

Metabolic Disorders

Others

Islet Amyloid Polypeptide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Islet Amyloid Polypeptide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Islet Amyloid Polypeptide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Islet Amyloid Polypeptide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Islet Amyloid Polypeptide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Islet Amyloid Polypeptide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Islet Amyloid Polypeptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Islet Amyloid Polypeptide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Islet Amyloid Polypeptide Industry Trends Table 2. Islet Amyloid Polypeptide Industry Drivers Table 3. Islet Amyloid Polypeptide Industry Opportunities and Challenges Table 4. Islet Amyloid Polypeptide Industry Restraints Table 5. Global Islet Amyloid Polypeptide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Islet Amyloid Polypeptide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Islet Amyloid Polypeptide Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Islet Amyloid Polypeptide Sales Market Share by Manufacturers Table 9. Global Islet Amyloid Polypeptide Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Islet Amyloid Polypeptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Islet Amyloid Polypeptide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Islet Amyloid Polypeptide Manufacturers, Product Type & Application Table 13. Global Islet Amyloid Polypeptide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Islet Amyloid Polypeptide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of KBP-088 Table 17. Major Manufacturers of KBP-056 Table 18. Major Manufacturers of DACRA-089 Table 19. Major Manufacturers of DACRA-042 Table 20. Major Manufacturers of AC-253 Table 21. Major Manufacturers of Others Table 22. Global Islet Amyloid Polypeptide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Islet Amyloid Polypeptide Sales by Type (2021-2026) & (K Units) Table 24. Global Islet Amyloid Polypeptide Sales by Type (2027-2032) & (K Units) Table 25. Global Islet Amyloid Polypeptide Sales Market Share by Type (2021-2026) Table 26. Global Islet Amyloid Polypeptide Sales Market Share by Type (2027-2032) Table 27. Global Islet Amyloid Polypeptide Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Islet Amyloid Polypeptide Revenue by Type (2021-2026) & (K Units) Table 29. Global Islet Amyloid Polypeptide Revenue by Type (2027-2032) & (K Units) Table 30. Global Islet Amyloid Polypeptide Revenue Market Share by Type (2021-2026) Table 31. Global Islet Amyloid Polypeptide Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Gastrointestinal Table 33. Major Manufacturers of Musculoskeletal Disorders Table 34. Major Manufacturers of Metabolic Disorders Table 35. Major Manufacturers of Others Table 36. Global Islet Amyloid Polypeptide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Islet Amyloid Polypeptide Sales by Application (2021-2026) & (K Units) Table 38. Global Islet Amyloid Polypeptide Sales by Application (2027-2032) & (K Units) Table 39. Global Islet Amyloid Polypeptide Sales Market Share by Application (2021-2026) Table 40. Global Islet Amyloid Polypeptide Sales Market Share by Application (2027-2032) Table 41. Global Islet Amyloid Polypeptide Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Islet Amyloid Polypeptide Revenue by Application (2021-2026) & (K Units) Table 43. Global Islet Amyloid Polypeptide Revenue by Application (2027-2032) & (K Units) Table 44. Global Islet Amyloid Polypeptide Revenue Market Share by Application (2021-2026) Table 45. Global Islet Amyloid Polypeptide Revenue Market Share by Application (2027-2032) Table 46. Global Islet Amyloid Polypeptide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Islet Amyloid Polypeptide Sales by Region (2021-2026) & (K Units) Table 48. Global Islet Amyloid Polypeptide Sales Market Share by Region (2021-2026) Table 49. Global Islet Amyloid Polypeptide Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Islet Amyloid Polypeptide Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 53. North America Islet Amyloid Polypeptide Sales by Country (2027-2032) & (K Units) Table 54. Europe Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 56. Europe Islet Amyloid Polypeptide Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Islet Amyloid Polypeptide Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Islet Amyloid Polypeptide Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Islet Amyloid Polypeptide Sales by Country (2027-2032) & (K Units) Table 63. Global Islet Amyloid Polypeptide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Islet Amyloid Polypeptide Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Islet Amyloid Polypeptide Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Islet Amyloid Polypeptide Revenue Market Share by Region (2021-2026) Table 67. Global Islet Amyloid Polypeptide Revenue Market Share by Region (2027-2032) Table 68. Adocia SAS Company Information Table 69. Adocia SAS Business Overview Table 70. Adocia SAS Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Adocia SAS Islet Amyloid Polypeptide Product Portfolio Table 72. Adocia SAS Recent Development Table 73. Neurimmune Holding AG Company Information Table 74. Neurimmune Holding AG Business Overview Table 75. Neurimmune Holding AG Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Neurimmune Holding AG Islet Amyloid Polypeptide Product Portfolio Table 77. Neurimmune Holding AG Recent Development Table 78. Nordic Bioscience A/S Company Information Table 79. Nordic Bioscience A/S Business Overview Table 80. Nordic Bioscience A/S Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Nordic Bioscience A/S Islet Amyloid Polypeptide Product Portfolio Table 82. Nordic Bioscience A/S Recent Development Table 83. Prothena Corp Plc Company Information Table 84. Prothena Corp Plc Business Overview Table 85. Prothena Corp Plc Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Prothena Corp Plc Islet Amyloid Polypeptide Product Portfolio Table 87. Prothena Corp Plc Recent Development Table 88. reMYND NV Company Information Table 89. reMYND NV Business Overview Table 90. reMYND NV Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. reMYND NV Islet Amyloid Polypeptide Product Portfolio Table 92. reMYND NV Recent Development Table 93. Zealand Pharma AS Company Information Table 94. Zealand Pharma AS Business Overview Table 95. Zealand Pharma AS Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Zealand Pharma AS Islet Amyloid Polypeptide Product Portfolio Table 97. Zealand Pharma AS Recent Development Table 98. AstraZeneca Plc Company Information Table 99. AstraZeneca Plc Business Overview Table 100. AstraZeneca Plc Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. AstraZeneca Plc Islet Amyloid Polypeptide Product Portfolio Table 102. AstraZeneca Plc Recent Development Table 103. Eli Lilly and Co Company Information Table 104. Eli Lilly and Co Business Overview Table 105. Eli Lilly and Co Islet Amyloid Polypeptide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Eli Lilly and Co Islet Amyloid Polypeptide Product Portfolio Table 107. Eli Lilly and Co Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Islet Amyloid Polypeptide Distributors List Table 111. Islet Amyloid Polypeptide Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Islet Amyloid Polypeptide Product Image Figure 2. Global Islet Amyloid Polypeptide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Islet Amyloid Polypeptide Market Size (2021-2032) & (US$ Million) Figure 4. Global Islet Amyloid Polypeptide Sales (2021-2032) & (K Units) Figure 5. Global Islet Amyloid Polypeptide Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Islet Amyloid Polypeptide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. KBP-088 Image Figure 9. KBP-056 Image Figure 10. DACRA-089 Image Figure 11. DACRA-042 Image Figure 12. AC-253 Image Figure 13. Others Image Figure 14. Global Islet Amyloid Polypeptide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Islet Amyloid Polypeptide Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Islet Amyloid Polypeptide Sales Market Share by Type (2021-2032) Figure 17. Global Islet Amyloid Polypeptide Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Islet Amyloid Polypeptide Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Islet Amyloid Polypeptide Revenue Market Share by Type (2021-2032) Figure 20. Gastrointestinal Image Figure 21. Musculoskeletal Disorders Image Figure 22. Metabolic Disorders Image Figure 23. Others Image Figure 24. Global Islet Amyloid Polypeptide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Islet Amyloid Polypeptide Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Islet Amyloid Polypeptide Sales Market Share by Application (2021-2032) Figure 27. Global Islet Amyloid Polypeptide Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Islet Amyloid Polypeptide Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Islet Amyloid Polypeptide Revenue Market Share by Application (2021-2032) Figure 30. North America Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Islet Amyloid Polypeptide Sales Market Share by Country (2021-2032) Figure 32. U.S. Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Islet Amyloid Polypeptide Sales Market Share by Country (2021-2032) Figure 37. Germany Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Islet Amyloid Polypeptide Sales Market Share by Country (2021-2032) Figure 44. China Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Islet Amyloid Polypeptide Sales Market Share by Country (2021-2032) Figure 52. Brazil Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Islet Amyloid Polypeptide Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Islet Amyloid Polypeptide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Islet Amyloid Polypeptide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Islet Amyloid Polypeptide Revenue (2021-2032) & (US$ Million) Figure 63. North America Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Islet Amyloid Polypeptide Revenue (2021-2032) & (US$ Million) Figure 65. Europe Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Islet Amyloid Polypeptide Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Islet Amyloid Polypeptide Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Islet Amyloid Polypeptide Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Islet Amyloid Polypeptide Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • KBP-088
  • KBP-056
  • DACRA-089
  • DACRA-042
  • AC-253
  • Others
Applications
  • Gastrointestinal
  • Musculoskeletal Disorders
  • Metabolic Disorders
  • Others
Companies covered
  • Adocia SAS
  • Neurimmune Holding AG
  • Nordic Bioscience A/S
  • Prothena Corp Plc
  • reMYND NV
  • Zealand Pharma AS
  • AstraZeneca Plc
  • Eli Lilly and Co

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Islet Amyloid Polypeptide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Islet Amyloid Polypeptide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Islet Amyloid Polypeptide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Islet Amyloid Polypeptide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Islet Amyloid Polypeptide Market Dynamics
  1. 2.1 Islet Amyloid Polypeptide Industry Trends
  2. 2.2 Islet Amyloid Polypeptide Industry Drivers
  3. 2.3 Islet Amyloid Polypeptide Industry Opportunities and Challenges
  4. 2.4 Islet Amyloid Polypeptide Industry Restraints
3 Islet Amyloid Polypeptide Market by Manufacturers
  1. 3.1 Global Islet Amyloid Polypeptide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Islet Amyloid Polypeptide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Islet Amyloid Polypeptide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Islet Amyloid Polypeptide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Islet Amyloid Polypeptide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Islet Amyloid Polypeptide Manufacturers, Product Type & Application
  7. 3.7 Global Islet Amyloid Polypeptide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Islet Amyloid Polypeptide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Islet Amyloid Polypeptide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Islet Amyloid Polypeptide Tier 1, Tier 2, and Tier 3
4 Islet Amyloid Polypeptide Market by Type
  1. 4.1 Islet Amyloid Polypeptide Type Introduction
  2. 4.1.1 KBP-088
  3. 4.1.2 KBP-056
  4. 4.1.3 DACRA-089
  5. 4.1.4 DACRA-042
  6. 4.1.5 AC-253
  7. 4.1.6 Others
  8. 4.2 Global Islet Amyloid Polypeptide Sales by Type
  9. 4.2.1 Global Islet Amyloid Polypeptide Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Islet Amyloid Polypeptide Sales by Type (2021-2032)
  11. 4.2.3 Global Islet Amyloid Polypeptide Sales Market Share by Type (2021-2032)
  12. 4.3 Global Islet Amyloid Polypeptide Revenue by Type
  13. 4.3.1 Global Islet Amyloid Polypeptide Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Islet Amyloid Polypeptide Revenue by Type (2021-2032)
  15. 4.3.3 Global Islet Amyloid Polypeptide Revenue Market Share by Type (2021-2032)
5 Islet Amyloid Polypeptide Market by Application
  1. 5.1 Islet Amyloid Polypeptide Application Introduction
  2. 5.1.1 Gastrointestinal
  3. 5.1.2 Musculoskeletal Disorders
  4. 5.1.3 Metabolic Disorders
  5. 5.1.4 Others
  6. 5.2 Global Islet Amyloid Polypeptide Sales by Application
  7. 5.2.1 Global Islet Amyloid Polypeptide Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Islet Amyloid Polypeptide Sales by Application (2021-2032)
  9. 5.2.3 Global Islet Amyloid Polypeptide Sales Market Share by Application (2021-2032)
  10. 5.3 Global Islet Amyloid Polypeptide Revenue by Application
  11. 5.3.1 Global Islet Amyloid Polypeptide Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Islet Amyloid Polypeptide Revenue by Application (2021-2032)
  13. 5.3.3 Global Islet Amyloid Polypeptide Revenue Market Share by Application (2021-2032)
6 Global Islet Amyloid Polypeptide Sales by Region
  1. 6.1 Global Islet Amyloid Polypeptide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Islet Amyloid Polypeptide Sales by Region (2021-2032)
  3. 6.2.1 Global Islet Amyloid Polypeptide Sales by Region (2021-2026)
  4. 6.2.2 Global Islet Amyloid Polypeptide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Islet Amyloid Polypeptide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Islet Amyloid Polypeptide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Islet Amyloid Polypeptide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Islet Amyloid Polypeptide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Islet Amyloid Polypeptide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Islet Amyloid Polypeptide Revenue by Region
  1. 7.1 Global Islet Amyloid Polypeptide Revenue by Region
  2. 7.1.1 Global Islet Amyloid Polypeptide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Islet Amyloid Polypeptide Revenue by Region (2021-2026)
  4. 7.1.3 Global Islet Amyloid Polypeptide Revenue by Region (2027-2032)
  5. 7.1.4 Global Islet Amyloid Polypeptide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Islet Amyloid Polypeptide Revenue (2021-2032)
  8. 7.2.2 North America Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Islet Amyloid Polypeptide Revenue (2021-2032)
  11. 7.3.2 Europe Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Islet Amyloid Polypeptide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Islet Amyloid Polypeptide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Islet Amyloid Polypeptide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Adocia SAS
  2. 8.1.1 Adocia SAS Company Information
  3. 8.1.2 Adocia SAS Business Overview
  4. 8.1.3 Adocia SAS Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Adocia SAS Islet Amyloid Polypeptide Product Portfolio
  6. 8.1.5 Adocia SAS Recent Developments
  7. 8.2 Neurimmune Holding AG
  8. 8.2.1 Neurimmune Holding AG Company Information
  9. 8.2.2 Neurimmune Holding AG Business Overview
  10. 8.2.3 Neurimmune Holding AG Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Neurimmune Holding AG Islet Amyloid Polypeptide Product Portfolio
  12. 8.2.5 Neurimmune Holding AG Recent Developments
  13. 8.3 Nordic Bioscience A/S
  14. 8.3.1 Nordic Bioscience A/S Company Information
  15. 8.3.2 Nordic Bioscience A/S Business Overview
  16. 8.3.3 Nordic Bioscience A/S Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Nordic Bioscience A/S Islet Amyloid Polypeptide Product Portfolio
  18. 8.3.5 Nordic Bioscience A/S Recent Developments
  19. 8.4 Prothena Corp Plc
  20. 8.4.1 Prothena Corp Plc Company Information
  21. 8.4.2 Prothena Corp Plc Business Overview
  22. 8.4.3 Prothena Corp Plc Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Prothena Corp Plc Islet Amyloid Polypeptide Product Portfolio
  24. 8.4.5 Prothena Corp Plc Recent Developments
  25. 8.5 reMYND NV
  26. 8.5.1 reMYND NV Company Information
  27. 8.5.2 reMYND NV Business Overview
  28. 8.5.3 reMYND NV Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 reMYND NV Islet Amyloid Polypeptide Product Portfolio
  30. 8.5.5 reMYND NV Recent Developments
  31. 8.6 Zealand Pharma AS
  32. 8.6.1 Zealand Pharma AS Company Information
  33. 8.6.2 Zealand Pharma AS Business Overview
  34. 8.6.3 Zealand Pharma AS Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Zealand Pharma AS Islet Amyloid Polypeptide Product Portfolio
  36. 8.6.5 Zealand Pharma AS Recent Developments
  37. 8.7 AstraZeneca Plc
  38. 8.7.1 AstraZeneca Plc Company Information
  39. 8.7.2 AstraZeneca Plc Business Overview
  40. 8.7.3 AstraZeneca Plc Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Plc Islet Amyloid Polypeptide Product Portfolio
  42. 8.7.5 AstraZeneca Plc Recent Developments
  43. 8.8 Eli Lilly and Co
  44. 8.8.1 Eli Lilly and Co Company Information
  45. 8.8.2 Eli Lilly and Co Business Overview
  46. 8.8.3 Eli Lilly and Co Islet Amyloid Polypeptide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Eli Lilly and Co Islet Amyloid Polypeptide Product Portfolio
  48. 8.8.5 Eli Lilly and Co Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Islet Amyloid Polypeptide Value Chain Analysis
  2. 9.1.1 Islet Amyloid Polypeptide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Islet Amyloid Polypeptide Production Mode & Process
  6. 9.2 Islet Amyloid Polypeptide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Islet Amyloid Polypeptide Distributors
  9. 9.2.3 Islet Amyloid Polypeptide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst